Novel treatment avenues for peripheral T-cell lymphomas

By Hopfinger Georg   Griessl Robert   Sifft Eveline   Taylor Ninon   Kenner Lukas   Greil Richard   Merkel Olaf  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 12, 2012-12 ,pp. : 1149-1163

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs in cutaneous T-cell lymphomas

By Dummer Reinhard  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 381-392

Informa Healthcare

Access to resources Recommend Favorite

Transcription Factor Profiling Shows New Ways Towards New Treatment Options of Cutaneous T cell lymphomas

By  

Current Drug Discovery Technologies, Vol. 4, Iss. 1, 2007-06 ,pp. : 24-30

Bentham Science Publishers

Access to resources Recommend Favorite

A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas

By Kim Seok   Kang Hye   Kim Jin   Eom Hyeon-Seok   Huh Jooryung   Ko Young   Lee Jongtae   Yim Dong-Seok   Lee Soo-Youn   Park Weon   Yang Woo   Lee Seung-Sook   Suh Cheolwon   Kim Won  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1514-1521

Springer Publishing Company

Access to resources Recommend Favorite

Impact of comorbidity on survival in peripheral T‐cell lymphomas: A Swedish Lymphoma Registry study

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 159-165

John Wiley & Sons Inc

Access to resources Recommend Favorite